Bamco Inc. NY Reduces Stock Position in The Cooper Companies, Inc. $COO

Bamco Inc. NY cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 25.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 663,738 shares of the medical device company’s stock after selling 225,716 shares during the quarter. Bamco Inc. NY owned approximately 0.33% of Cooper Companies worth $45,506,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of COO. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies in the 2nd quarter worth approximately $36,000. MUFG Securities EMEA plc purchased a new position in shares of Cooper Companies during the second quarter valued at approximately $42,000. Quent Capital LLC bought a new position in shares of Cooper Companies during the third quarter valued at approximately $44,000. Mather Group LLC. purchased a new stake in Cooper Companies in the third quarter worth $56,000. Finally, Federated Hermes Inc. bought a new stake in Cooper Companies in the third quarter valued at $58,000. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on COO. Piper Sandler reissued an “overweight” rating and set a $94.00 price objective (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Citigroup dropped their target price on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, March 6th. Needham & Company LLC lifted their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. Finally, Morgan Stanley increased their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Insiders Place Their Bets

In related news, Director Maria Rivas bought 1,000 shares of the business’s stock in a transaction dated Thursday, December 18th. The shares were purchased at an average cost of $82.13 per share, with a total value of $82,130.00. Following the completion of the purchase, the director owned 11,141 shares in the company, valued at approximately $915,010.33. The trade was a 9.86% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies stock in a transaction dated Wednesday, December 17th. The shares were bought at an average price of $82.50 per share, with a total value of $165,000.00. Following the completion of the acquisition, the director directly owned 7,777 shares of the company’s stock, valued at approximately $641,602.50. This represents a 34.62% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders purchased 16,014 shares of company stock valued at $1,304,416. Company insiders own 2.08% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO stock opened at $69.92 on Monday. The company’s fifty day moving average price is $81.23 and its 200-day moving average price is $75.97. The stock has a market cap of $13.64 billion, a PE ratio of 34.61, a price-to-earnings-growth ratio of 1.80 and a beta of 1.02. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same period last year, the business earned $0.92 EPS. Cooper Companies’s quarterly revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.